Role of aggregate-forming pilus (AFP) in adherence and colonization of both intestinal and urinary tracts

Virulence. 2022 Dec;13(1):1423-1433. doi: 10.1080/21505594.2022.2112818.

Abstract

Hybrid-pathogenic Escherichia coli represent an important group of strains associated with intestinal and extraintestinal infections. Recently, we described strain UPEC-46, a uropathogenic/enteroaggregative E. coli (UPEC/EAEC) strain presenting the aggregative adherence (AA) pattern on bladder and colorectal epithelial cells mediated by aggregate-forming pili (AFP). However, the role of AFP and other uninvestigated putative fimbriae operons in UPEC-46 pathogenesis remains unclear. Thus, this study evaluated the involvement of AFP and other adhesins in uropathogenicity and intestinal colonization using different in vitro and in vivo models. The strain UPEC-46 was able to adhere and invade intestinal and urinary cell lines. A library of transposon mutants also identified the involvement of type I fimbriae (TIF) in the adherence to HeLa cells, in addition to colorectal and bladder cell lines. The streptomycin-treated mouse in vivo model also showed an increased number of bacterial counts in the colon in the presence of AFP and TIF. In the mouse model of ascending urinary tract infection (UTI), AFP was more associated with kidney colonization, while TIF appears to mediate bladder colonization. Results observed in in vivo experiments were also confirmed by electron microscopy (EM) analyses. In summary, the in vitro and in vivo analyses show a synergistic role of AFP and TIF in the adherence and colonization of intestinal and urinary epithelia. Therefore, we propose that hybrid E. coli strains carrying AFP and TIF could potentially cause intestinal and urinary tract infections in the same patient.

Keywords: AFP; Hybrid-pathogenicE. coli; aggregate-forming pilus; intestinal colonization; urinary tract infection.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Bacterial Adhesion*
  • Escherichia coli / pathogenicity
  • Escherichia coli Infections* / microbiology
  • Fimbriae, Bacterial*
  • HeLa Cells
  • Humans
  • Intestines / microbiology
  • Mice
  • Urinary Tract / microbiology
  • Urinary Tract Infections* / microbiology
  • Uropathogenic Escherichia coli* / pathogenicity

Grants and funding

This study was supported by Grants from São Paulo Research Foundation (FAPESP 2018/06610-9 and 2018/04144-0); Coordenação de Aperfeiçoamento de Pessoal de Nível Superior – Brasil (CAPES) – Finance Code 001; Brazil Centre of the University of Münster, under the auspices of the German Academic Exchange Service (DAAD) and the German Federal Ministry of Education and Research (grant number 01DN19008).